Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey S Mohlman

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The American Journal of Dermatopathology|March 25, 2015
Cutaneous epithelioid osteoblastomaJeffrey S Mohlman, Katherine A Diaz, John D Schaber
Laboratory Medicine|September 1, 2018
Reliability and Validity of Proposed Risk Stratification Methods for Laboratory Developed TestsJeffrey S Mohlman, Jonathan R Genzen, Ronald L Weiss, et al.
American Journal of Clinical Pathology|February 19, 2020
Improving Augmented Human Intelligence to Distinguish Burkitt Lymphoma From Diffuse Large B-Cell Lymphoma CasesJeffrey S Mohlman, Samuel D Leventhal, Taft Hansen, et al.
Clinical Chemistry|July 9, 2017
Laboratory-Developed Tests: A Legislative and Regulatory ReviewJonathan R Genzen, Jeffrey S Mohlman, Jerry L Lynch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 2021
Correction: Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney CancerSophie J Cowman, Daniel G Fuja, Xian-De Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2020
Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney CancerSophie J Cowman, Daniel G Fuja, Xian-De Liu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The American Journal of Dermatopathology|March 25, 2015
Cutaneous epithelioid osteoblastomaJeffrey S Mohlman, Katherine A Diaz, John D Schaber
Laboratory Medicine|September 1, 2018
Reliability and Validity of Proposed Risk Stratification Methods for Laboratory Developed TestsJeffrey S Mohlman, Jonathan R Genzen, Ronald L Weiss, et al.
American Journal of Clinical Pathology|February 19, 2020
Improving Augmented Human Intelligence to Distinguish Burkitt Lymphoma From Diffuse Large B-Cell Lymphoma CasesJeffrey S Mohlman, Samuel D Leventhal, Taft Hansen, et al.
Clinical Chemistry|July 9, 2017
Laboratory-Developed Tests: A Legislative and Regulatory ReviewJonathan R Genzen, Jeffrey S Mohlman, Jerry L Lynch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 2021
Correction: Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney CancerSophie J Cowman, Daniel G Fuja, Xian-De Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2020
Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney CancerSophie J Cowman, Daniel G Fuja, Xian-De Liu, et al.
Pageof 1